Evidence map›Paper›PMID 19788801›Full record

ReviewEmerging infectious diseases2009

Extrapulmonary infections associated with nontuberculous mycobacteria in immunocompetent persons.

Claudio Piersimoni, Claudio Scarparo

Open access · diamondAbstract readReview
In one paragraph

Review in Emerging infectious diseases, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 109 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
109citing papers in PubMed, 2 pooled it
8.2field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

109 citing papers in PubMed, 2 syntheses or guidelines pooled it, 255 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Review
  12. Review
  13. Extrapulmonary Comparisons BetweenInfection and drug resistance · 2025
    Review
  14. PulmonaryJournal of community hospital internal medicine perspectives · 2025
    Article
  15. Toward better cures forClinical microbiology reviews · 2024
    Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Broad-Spectrum In Vitro Activity ofAntibiotics (Basel, Switzerland) · 2024
    Article

49 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Claudio PiersimoniDepartment of Clinical Microbiology, United Hospitals, via Conca 71, I-60020 Ancona, Italy. piersim@tin.it
Claudio Scarparo
United Hospital · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Over the past several years, the prevalence of human disease caused by nontuberculous mycobacteria (NTM) has increased. Whether the increase in cases is real or whether more cases are being recognized remains unclear. Despite a considerable increase in knowledge about NTM infections, they still represent a diagnostic and therapeutic challenge for several reasons: 1) pathogenic isolates may be indistinguishable from contaminant or saprophytic isolates; 2) timely and reliable identification of isolates may depend on proper communication between clinicians and laboratory staff; 3) lack of standardized susceptibility testing makes adoption of tailored therapies unrealistic; and 4) lack of treatment guidelines exposes patients to toxic drugs and disappointing outcomes. Laboratory research and multicenter controlled trials are needed to improve diagnosis and treatment of these infections.

Indexed as

ImmunocompetenceLymphadenitisMycobacteriumMycobacterium InfectionsSkin Diseases, BacterialSoft Tissue InfectionsTuberculosis, OsteoarticularAdultAnimalsChild, PreschoolHumansInfantMycobacterium Infections, NontuberculousMycobacterium marinumNontuberculous MycobacteriaPrevalence

Identifiers

PMID19788801
PMCPMC2819852
OpenAlexW2121318680

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.